Pharmacodynamic Data News Today

Press release content from Business Wire. The AP news staff was not involved in its creation. New Genentech Data at 2021 AAN Highlight Impact and Breadth of Expanding Neuroscience Portfolio April 8, 2021 GMT SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Apr 8, 2021-- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that new data for its approved and investigational medicines for the treatment of neurological disorders will be presented at the 73rd American Ac...

(0) EVRYSDI 2-year FIREFISH Part 2 data show improvement in motor function in infants with Type 1 spinal muscular atrophy (SMA) OCREVUS data show its consistent benefit on slowing disease progression in relapsing multiple sclerosis (RMS) and primary progressive MS (PPMS) Data for ENSPRYNG in neuromyelitis optica spectrum disorder (NMOSD) reinforce safety and efficacy, including in patients with concomitant autoimmune diseases (CAIDs) Data for investigational MS medicine fenebrutinib support it...